Sign up to save your podcasts
Or
Share The HIV Vaccine's Path Through Clinical Trials: A Biotech CEO's Perspective
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The HIV Vaccine's Path Through Clinical Trials: A Biotech CEO's Perspective
Host: Matt Birnholz, MD
Guest: Robert McNally, MD
From the Villanova Health Summit's Speaker Event, host Dr. Matt Birnholz speaks with guest Dr. Robert McNally, President, and CEO of GeoVax, Inc. They discuss the challenges that biotech companies face when bringing vaccines through clinical trials, and the long-term project being conducted by his colleagues to deliver an HIV vaccine to market.
View all episodes
Host: Matt Birnholz, MD
Guest: Robert McNally, MD
From the Villanova Health Summit's Speaker Event, host Dr. Matt Birnholz speaks with guest Dr. Robert McNally, President, and CEO of GeoVax, Inc. They discuss the challenges that biotech companies face when bringing vaccines through clinical trials, and the long-term project being conducted by his colleagues to deliver an HIV vaccine to market.